Showing results (31-40 of 210) with videos related to
Sort By:
Pageof 21
Atherosclerosis|April 16, 2017
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemiaHidenori Arai, Shizuya Yamashita, Koutaro Yokote, et al.Diabetes Research and Clinical Practice|September 12, 2006
Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndromeNoboru Furukawa, Nobuhiro Miyamura, Kenro Nishida, et al.Journal of Clinical Lipidology|August 6, 2018
Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemiaShizuya Yamashita, Hidenori Arai, Koutaro Yokote, et al.Biochemical and Biophysical Research Communications|June 30, 2020
Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genesYuichi Kariba, Tatsuya Yoshizawa, Yoshifumi Sato, et al.Diabetes, Obesity & Metabolism|August 5, 2016
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetesNobuya Inagaki, Eiichi Araki, Tomonori Oura, et al.Surgical Neurology International|January 7, 2022
Atypical pituitary abscess lacking rim enhancement and diffusion restriction with an unusual organism, <i>Moraxella catarrhalis</i>: A case report and review of the literatureTatsuya Kawano, Naoki Shinojima, Satoko Hanatani, et al.Journal of Clinical Lipidology|December 6, 2017
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trialShun Ishibashi, Hidenori Arai, Koutaro Yokote, et al.Rinsho Shinkeigaku = Clinical Neurology|August 27, 2005
[A case of MELAS presenting juvenile-onset hyperglycemic chorea-ballism]Hideaki Nakagaki, Jun-ichiro Furuya, Yo Santa, et al.Biochemical and Biophysical Research Communications|May 10, 2011
Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic miceHironori Adachi, Tatsuya Kondo, Gou Young Koh, et al.The Journal of Clinical Investigation|February 21, 2002
Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetesSeiichi Oyadomari, Akio Koizumi, Kiyoshi Takeda, et al.Pageof 21